Guided Therapeutics (GTHP) Retained Earnings (2010 - 2026)
Guided Therapeutics (GTHP) posted Retained Earnings of -$157.1 million for Q4 2025, down 208.16% sequentially from $145.2 million in Q3 2025, and down 210.21% YoY from $142.5 million in Q4 2024.
Guided Therapeutics (GTHP) Retained Earnings (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Retained Earnings for 16 years, with the latest figure at -$157.1 million in Q4 2025.
- Quarterly Retained Earnings fell 210.21% year-over-year to -$157.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$157.1 million (down 210.21% YoY) and the FY2025 annual result came in at -$157.1 million, down 210.21% from the prior year.
- Retained Earnings declined to -$157.1 million in Q4 2025 per GTHP's latest filing, from $145.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at $145.2 million in Q3 2025 and troughed at -$157.1 million in Q4 2025.
- A 5-year average of $24.1 million and a median of $131.6 million in 2021 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 20160.33% in 2021, down 5760.64% in 2021.
- Over 5 years, Retained Earnings stood at $126.8 million in 2021, then rose by 8.9% to $138.1 million in 2022, then increased by 2.1% to $141.0 million in 2023, then climbed by 1.08% to $142.5 million in 2024, then plunged by 210.21% to -$157.1 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$157.1 million, $145.2 million, and $144.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 49.79 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.82 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 32.64 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.82 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 14.86 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.88 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 6.78 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.15 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | -158.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -158.67 Mn |
| Dec 31, 2025 | -157.06 Mn |
| Sep 30, 2025 | 145.21 Mn |
| Jun 30, 2025 | 144.04 Mn |
| Mar 31, 2025 | 143.62 Mn |
| Dec 31, 2024 | 142.50 Mn |
| Sep 30, 2024 | 141.76 Mn |
| Jun 30, 2024 | -152.32 Mn |
| Mar 31, 2024 | -151.56 Mn |
| Dec 31, 2023 | 140.98 Mn |
| Sep 30, 2023 | -150.65 Mn |
| Jun 30, 2023 | 140.29 Mn |
| Mar 31, 2023 | 139.13 Mn |
| Dec 31, 2022 | 138.09 Mn |
| Sep 30, 2022 | 136.37 Mn |
| Jun 30, 2022 | -144.45 Mn |
| Mar 31, 2022 | -143.44 Mn |
| Dec 31, 2021 | 126.80 Mn |
| Sep 30, 2021 | -141.88 Mn |
| Jun 30, 2021 | -141.83 Mn |